231 related articles for article (PubMed ID: 9617836)
1. Capture-ELISA based on recombinant PR3 is sensitive for PR3-ANCA testing and allows detection of PR3 and PR3-ANCA/PR3 immunecomplexes.
Sun J; Fass DN; Hudson JA; Viss MA; Wieslander J; Homburger HA; Specks U
J Immunol Methods; 1998 Feb; 211(1-2):111-23. PubMed ID: 9617836
[TBL] [Abstract][Full Text] [Related]
2. Recombinant proteinase 3 produced in different expression systems: recognition by anti-PR3 antibodies.
van der Geld YM; Oost-Kort W; Limburg PC; Specks U; Kallenberg CG
J Immunol Methods; 2000 Oct; 244(1-2):117-31. PubMed ID: 11033024
[TBL] [Abstract][Full Text] [Related]
3. Human mast cells expressing recombinant proteinase 3 (PR3) as substrate for clinical testing for anti-neutrophil cytoplasmic antibodies (ANCA).
Specks U; Wiegert EM; Homburger HA
Clin Exp Immunol; 1997 Aug; 109(2):286-95. PubMed ID: 9276524
[TBL] [Abstract][Full Text] [Related]
4. A novel capture-ELISA for detection of anti-neutrophil cytoplasmic antibodies (ANCA) based on c-myc peptide recognition in carboxy-terminally tagged recombinant neutrophil serine proteases.
Lee AS; Finkielman JD; Peikert T; Hummel AM; Viss MA; Specks U
J Immunol Methods; 2005 Dec; 307(1-2):62-72. PubMed ID: 16242707
[TBL] [Abstract][Full Text] [Related]
5. Characterization of monoclonal antibodies to proteinase 3 (PR3) as candidate tools for epitope mapping of human anti-PR3 autoantibodies.
Van Der Geld YM; Limburg PC; Kallenberg CG
Clin Exp Immunol; 1999 Dec; 118(3):487-96. PubMed ID: 10594572
[TBL] [Abstract][Full Text] [Related]
6. A proportion of proteinase 3 (PR3)-specific anti-neutrophil cytoplasmic antibodies (ANCA) only react with PR3 after cleavage of its N-terminal activation dipeptide.
Sun J; Fass DN; Viss MA; Hummel AM; Tang H; Homburger HA; Specks U
Clin Exp Immunol; 1998 Nov; 114(2):320-6. PubMed ID: 9822293
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody.
Westman KW; Selga D; Bygren P; Segelmark M; Baslund B; Wiik A; Wieslander J
Kidney Int; 1998 May; 53(5):1230-6. PubMed ID: 9573537
[TBL] [Abstract][Full Text] [Related]
8. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis.
Csernok E; Ahlquist D; Ullrich S; Gross WL
Rheumatology (Oxford); 2002 Nov; 41(11):1313-7. PubMed ID: 12422006
[TBL] [Abstract][Full Text] [Related]
9. Measurements of proteinase 3 and its complexes with alpha 1-proteinase inhibitor and anti-neutrophil cytoplasm antibodies (ANCA) in plasma.
Baslund B; Petersen J; Permin H; Wiik A; Wieslander J
J Immunol Methods; 1994 Oct; 175(2):215-25. PubMed ID: 7930650
[TBL] [Abstract][Full Text] [Related]
10. Discrimination and variable impact of ANCA binding to different surface epitopes on proteinase 3, the Wegener's autoantigen.
Silva F; Hummel AM; Jenne DE; Specks U
J Autoimmun; 2010 Dec; 35(4):299-308. PubMed ID: 20810247
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study.
Csernok E; Holle J; Hellmich B; Willem J; Tervaert C; Kallenberg CG; Limburg PC; Niles J; Pan G; Specks U; Westman K; Wieslander J; De Groot K; Gross WL
Rheumatology (Oxford); 2004 Feb; 43(2):174-80. PubMed ID: 14585921
[TBL] [Abstract][Full Text] [Related]
12. Screening for anti-neutrophil cytoplasmic antibodies (ANCA): is indirect immunofluorescence the method of choice?
Baslund B; Segelmark M; Wiik A; Szpirt W; Petersen J; Wieslander J
Clin Exp Immunol; 1995 Mar; 99(3):486-92. PubMed ID: 7882573
[TBL] [Abstract][Full Text] [Related]
13. Image analysis: a novel approach for the quantification of antineutrophil cytoplasmic antibody levels in patients with Wegener's granulomatosis.
Boomsma MM; Damoiseaux JG; Stegeman CA; Kallenberg CG; Patnaik M; Peter JB; Tervaert JW
J Immunol Methods; 2003 Mar; 274(1-2):27-35. PubMed ID: 12609530
[TBL] [Abstract][Full Text] [Related]
14. Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: epitope analysis using synthetic peptides.
Van Der Geld YM; Simpelaar A; Van Der Zee R; Tervaert JW; Stegeman CA; Limburg PC; Kallenberg CG
Kidney Int; 2001 Jan; 59(1):147-59. PubMed ID: 11135067
[TBL] [Abstract][Full Text] [Related]
15. Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener's granulomatosis and microscopic polyangiitis.
Russell KA; Fass DN; Specks U
Arthritis Rheum; 2001 Feb; 44(2):463-8. PubMed ID: 11229478
[TBL] [Abstract][Full Text] [Related]
16. Expression of recombinant proteinase 3, the autoantigen in Wegener's granulomatosis, in insect cells.
Van der Geld YM; Smook ML; Huitema MG; Harmsen MC; Limburg PC; Kallenberg CG
J Immunol Methods; 2002 Jun; 264(1-2):195-205. PubMed ID: 12191522
[TBL] [Abstract][Full Text] [Related]
17. A novel high sensitivity ELISA for detection of antineutrophil cytoplasm antibodies against proteinase-3.
Hellmich B; Csernok E; Fredenhagen G; Gross WL
Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S1-5. PubMed ID: 17428354
[TBL] [Abstract][Full Text] [Related]
18. Analytical and diagnostic accuracy of the EliA automated enzyme fluoroimmunoassay for antineutrophil cytoplasmic autoantibody detection.
Villalta D; Tonutti E; Tampoia M; Bizzaro N; Papisch W; Tozzoli R; Stella S
Clin Chem Lab Med; 2004; 42(10):1161-7. PubMed ID: 15552276
[TBL] [Abstract][Full Text] [Related]
19. Human anti-neutrophil cytoplasm autoantibodies to proteinase 3 (PR3-ANCA) bind to neutrophils.
Van Rossum AP; van der Geld YM; Limburg PC; Kallenberg CG
Kidney Int; 2005 Aug; 68(2):537-41. PubMed ID: 16014030
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human proteinase 3, the Wegener's autoantigen, expressed in HMC-1 cells is enzymatically active and recognized by c-ANCA.
Specks U; Fass DN; Fautsch MP; Hummel AM; Viss MA
FEBS Lett; 1996 Jul; 390(3):265-70. PubMed ID: 8706874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
